Skip to main content

Caliper to Distribute Trinean Platform in North America

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today announced an exclusive distribution deal with Belgium spectrophotometer firm Trinean covering its DropSense platform.

Caliper will distribute the system in North America under the name LabChip DS. Financial and other terms of the deal were not disclosed.

In a statement, Caliper said the LabChip DS instrument, an automated UV/Vis spectral analysis platform, allows researchers to analyze concentration levels of up to 96 nucleic acid and protein samples in a few minutes. The system complements Caliper's existing LabChip GXl and LabChip GXll platforms offering fluorescent, electrophoretic analysis of nucleic acid and protein fragments, the company added.

"Caliper is investing significant resources into developing new products, applications on our existing products, and third party collaborations, co-marketing and distribution agreements to further augment our aggressive move into the biotherapeutics and genomics markets," Kevin Hrusovsky, president and CEO of Caliper, said in a statement.